Oxycodone/Rutundine

羟考酮/罗通定

Report date: 2025/07/25 14:29:48

Base Information

Drug NameOxycodone/Rutundine
Drug Alias Name羟考酮罗通定片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonistsDopamine receptors antagonists
TargetsOpioid receptorsDopamine receptors
Therapy Area/IndicationsHeadacheDysmenorrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes OxycodoneRutundine
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Sihuan Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Toxicants And Drugs, Academy Of Military Medical Sciences, Chinese People'S Liberation ArmyBeijing Sihuan Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHeadacheDysmenorrhea
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A